-
Investor Relations
- Corporate Governance
- Investor Presentations
- Annual Reports
- Compliance and AML
- Sustainability
- Financial Information
- Shareholders Toolkit
- FAQs
- Investors’ Queries
-
-
Accounts
- Al Hayrat Account
- Current Account
- Fixed Deposits Account
- Money Maker Account
- Salary Transfer Account
- Starmaker Account
- Super Saver Account
Al Wajaha
- Overview
BBK Lite
- Overview
NRI
- NRI Services
Debit Cards
- Classic
- Gold
- Signature
- Infinite
Self-service Banking
- ATM
- Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- Debit Card Issuance Machines
Foreign Exchange
- Remittance
- American Express
-
Insurance
- Home Secura
- Motor Secura
- Travel Secura
Investment
- Bonds
- IPO
- Mutual Funds
- Real Estate Investment
-
Branches and Self-Service
- Branches
- ATM
- Deposit Machines
- Debit Card Issuance Machines
- Corporate Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- BBK Virtual
Contactless Payments
- Apple Pay
- Samsung Wallet
- Google Pay
- Garmin Pay
- Fitbit Pay
More Ways to Bank
- Mobile app & Online Banking
- eStatements
- BBK BanKey
- Corporate Deposit Card
- Debit Card
- Telebanking
- Open Banking
- AFAQ Payment System
Sign Language
- Sign Language Directory
-
-
-
Accounts
- Business Current Account
- Business Fixed Deposit Account
Cash Management
- Bankey eBanking
- Payroll Services
- Deposit Machines
- POS Credimax
- Remittance
-
Working Capital Finance
- Overdraft
- Cheque discounting
- Short Term Loans
Long Term Finance
- Project Finance
- Assets Finance
- Real estate Finance
-
Corporate Banking
- Government Affairs
- Real Estate, Services and Trading
- Contracting, Building Material, and Manufacturing
International Banking
- Overview
- Services
- NRI
- Offshore Branches
- Representative offices
Enterprise Banking
- Overview
-
-
-
-
FINANCIAL NEWS
Oman-Neopharma issues OMR92mn in pharmaceutical plant
23 May 2017
(MENAFN) Neopharma, one of region’s pioneering pharmaceutical manufacturing firms, has invested OMR92mn towards diabetes management in the GCC and global markets.
Additionally, these investments involve OMR10mn in a state-of-the-art Japanese factory, OMR28mn in the acquisition of patents and licenses and an extra investment in clinical studies.
Moreover, Neopharma Japan has obtained a 65 percent share in the Japanese pharmaceutical firm, Cosmo ALA to produce this dietary supplement.
Accordingly, almost 422mn people are diabetic worldwide, while the number is projected to spiral to 642mn by 2040.
MENAFN2305201700450000ID1095502651
MENAFN2305201700450000ID1095502651
More News
04 Aug 2025
HM the King’s Support for Youth is an Inspirational Model for Their Empowerment Journey
28 Jul 2025
BBK discloses its financial results for the half year ended 30th June 2025
20 Jul 2025
CBB approves the transfer of the retail banking operations of HSBC Bank Middle East, Bahrain Branch to BBK
08 Jul 2025
BBK proudly launches the third edition of “Grow” and welcomes 20 Bahraini graduates
03 Jul 2025
BBK hosts executive leadership session on digital assets in collaboration with Rain
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
16 Jun 2025
BBK and CrediMax Offer Exclusive 20% Discount on Turkish Airlines Flights for Cardholders
25 May 2025
BBK strengthens commitment to sports development through strategic partnership with Bahrain Basketball Association
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more